Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma
International Immunopharmacology · 2026-01 · 169 · 116014
DOI: 10.1016/j.intimp.2025.116014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-01. Verfasst von Zeyu Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biodiagnostic & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'a…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, CX3C Chemokine Receptor 1, CD8-Positive T-Lymphocytes, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Natural Science Basic Research Program of Shaanxi Province, National Natural Science Foundation of China, Xi'an Jiaotong University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National and Local Joint Engineering Research Center of Biodiagnostic & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China.
- Center for Precision Cancer Medicine, MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.
- Tumor and Immunology Center of Precision Medicine Institute, Xi'an Jiaotong University, Xi'an 710049, Shaanxi, China.
- National and Local Joint Engineering Research Center of Biodiagnostic & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China; Tumor and Immunology Center of Precision Med…
- National and Local Joint Engineering Research Center of Biodiagnostic & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China; Shaanxi Provincial Clinical Research Center…
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- National Natural Science Foundation of China
- Xi'an Jiaotong University
Zitieren
APA
Li, Z., Yuan, J., Du, F., Liu, N., Zhang, C., Huang, L., Feng, J., Zhang, C., Liu, X., Sun, J., He, G., Liu, G., Li, Z., & Tian, H. (2026). Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.116014
Vancouver
Li Z, Yuan J, Du F, Liu N, Zhang C, Huang L, et al. Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2025.116014
BibTeX
@article{Li2026,
author = {Li, Zeyu and Yuan, Jianing and Du, Fei and Liu, Nanbin and Zhang, Chunli and Huang, Limin and Feng, Jun and Zhang, Chen and Liu, Xi and Sun, Jin and He, Gaixia and Liu, Guoying and Li, Zongfang and Tian, Hongwei},
title = {Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2025.116014}
}
EUVIMED